Antimicrobial Resistance and Treatment of Community-Acquired Pneumonia Journal Articles

abstract

• This article discusses the problem of antimicrobial resistance and how it affects the management of community-acquired pneumonia (CAP). The discussion is limited to infection with Streptococcus pneumoniae and to the treatment of patients hospitalized in a medical ward or an intensive care unit because of pneumococcal CAP.

authors

• Mandell, Lionel

status

• published 

publication date

• March 2005

has subject area

• 1103 Clinical Sciences (FoR)
• Anti-Bacterial Agents (MeSH)
• Community-Acquired Infections (MeSH)
• Dose-Response Relationship, Drug (MeSH)
• Drug Resistance, Bacterial (MeSH)
• Drug Therapy, Combination (MeSH)
• Humans (MeSH)
• Pneumonia, Pneumococcal (MeSH)
• Respiratory System (Science Metrix)
• Streptococcus pneumoniae (MeSH)

published in

• Clinics in Chest Medicine  Journal

keywords

• Anti-Bacterial Agents
• Community-Acquired Infections
• Dose-Response Relationship, Drug
• Drug Resistance, Bacterial
• Drug Therapy, Combination
• Humans
• Pneumonia, Pneumococcal
• Streptococcus pneumoniae

Digital Object Identifier (DOI)

• 10.1016/j.ccm.2004.10.005

PubMed ID

• 15802166

start page

• 57

end page

• 64

volume

• 26

issue

• 1